echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > The research group of Wang Jinyong of the Institute of Zoology established a new technology to induce the differentiation and regeneration of NK cells from human pluripotent stem cells

    The research group of Wang Jinyong of the Institute of Zoology established a new technology to induce the differentiation and regeneration of NK cells from human pluripotent stem cells

    • Last Update: 2022-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
      

    On November 8, 2022, the research team of Wang Jinyong, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, and Beijing Institute of Stem Cell and Regenerative Medicine, published an online report on Cell Discovery Research paper on the Lateral plate mesoderm cell-based organoid system for NK cell regeneration from human pluripotent stem cells
    .
    In this study, high-purity side plate mesoblast cells and trophoblasts derived from human pluripotent stem cells were used for the first time to assemble organoid aggregates, and the gas-liquid interface was used for culture induction to achieve in vitro regeneration
    of NK cells (iNK).
    Compared with traditional methods, this induction strategy has the characteristics of
    short time-consuming, high yield, high maturity, no need for secondary amplification, and low cost.
    Killing tests for multiple tumor types confirmed broad-spectrum, highly effective anti-tumor activity
    of iNK cells.
    This study provides a new method
    for the large-scale preparation of human pluripotent stem cell-derived regenerative iNK cells.

    NK cells can directly kill various tumor cells in a broad spectrum, have few toxic side effects, and adoptive treatment does not require matching, which is an ideal spot immune cell therapy drug
    .
    At present, NK cells for clinical treatment are mainly derived from human tissues such as umbilical cord blood and peripheral blood, and these naturally derived NK cells are heterogeneous, with high preparation cost, low yield, and preparation cycle limited by human tissue
    accessibility.
    Human pluripotent stem cell-induced differentiation-derived NK cells are expected to solve the above problems
    .
    The traditional method of differentiation and regeneration of NK cells from pluripotent stem cells requires going through the embryoid body intermediate stage, and further large-scale expansion of feeding cells with the help of expansion feeder cells, and the activity of iNK cells obtained is poor
    .
    Wang Jinyong's research group has developed an organoid aggregate assembly method that does not rely on embryoid bodies and is based on the side plate mesoderm as the starting seed cell, so as to realize the efficient regeneration
    of iNK cells.
    In the 27-day induction cycle, millions of pluripotent stem cells can be invested to export more than one billion iNK cells
    .
    In this study, regenerative iNK cells are highly expressed with classical cytotoxic granules (perforin and granzyme B), apoptosis-inducing-related ligands (FasL and TRAIL), and a range of NK cell activating and inhibitory receptors
    .
    Functionally, iNK cells can kill human tumor cells
    by directly poisoning, inducing target apoptosis, and antibody-dependent cell-mediated cytotoxicity.
    This study provides key technical support for the large-scale production of off-the-shelf, universal and regenerative NK cell drugs, promotes the clinical transformation and application of iNK cells, and benefits patients
    .
    iNK cells prepared based on this technology have been used in clinical trials
    .

    Huang Dehao, postdoctoral fellow of the State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Li Jianhuan, doctoral student of Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences, and Dr.
    Hu Fangxiao and Dr.
    Xia Chengxiang, young scholars of Beijing Institute of Stem Cell and Regenerative Medicine, are the co-first authors of the paper, and Professor Wang Jinyong is the corresponding author
    of the paper.
    The research was supported
    by the National Key Research and Development Program, the Strategic Leading Science and Technology Project of the Chinese Academy of Sciences, and the National Natural Science Foundation of China Outstanding Youth Fund.
    The research has also been strongly supported
    by advanced platform departments such as the Laboratory Animal Center, the Instrument Center, and the National Stem Cell Resource Bank of the Institute of Zoology, Chinese Academy of Sciences.

    Original link: https://doi.
    org/10.
    1038/s41421-022-00467-2

    Figure: Schematic diagram of human pluripotent stem cell-induced regenerative NK cell technology

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.